Associate Director, Marketing
Orca BioSalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Devices, DiagnosticsIndustries
Requirements
Candidates should possess a Bachelor’s degree, preferably in physical or life sciences, statistics, or engineering, and a Master’s or PhD degree is preferred. A minimum of 7 years of experience is required, including 2-3 years of product management, product/solution marketing, product commercialization, or strategic consulting experience. Strong experience with oncology products, medical devices, or diagnostics is preferred, along with experience in FDA-regulated diagnostic or CDx tests and globally commercialized diagnostic products and regulations (e.g. IVDR, Japan PMDA).
Responsibilities
The Associate Director/Director of Product Management, Oncology will lead the development and commercialization of diagnostic and companion diagnostic (CDx) tests for Natera’s new/emerging MRD portfolio, developing the vision and 5-year planning for commercialization. This role will own the entire product lifecycle from concept to obsolescence, creating a strategic product roadmap, evaluating and prioritizing new features and programs, and defining product requirements. The individual will manage product performance, analyze data, identify improvement strategies, and develop business cases and financial models, conducting VOC interviews, market research, and competitive analysis to support market growth and product positioning. They will also provide updates to stakeholders and support product marketing in defining product positioning and delivering key collateral content.
Skills
Product Management
Product Roadmap
Market Research
Competitive Analysis
VOC (Voice of Customer)
Strategic Consulting
FDA Regulations
CDx Tests
Diagnostic Products
Financial Modeling
Business Cases
Natera
Genetic testing and diagnostics solutions provider
About Natera
Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.
Key Metrics
Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees